logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Diana Mendes

Pfizer Ltd.

15H-index
135Paper Count
1.4KCitation Count
Published Papers 31
Publication Date
logo
Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants
errHuman Vaccines & Immunotherapeutics
IF0
err2026-07-28
err0
errOAAI
errAhmed El Hag; Nardine Nabil; Rowan El Masry; Elsayed Elbadawy Awad; Eman Mahmoud Fouda; Moataza Bashir Hamed; Yasser Abou Talib; Amy Law; Diana Mendes; Mohamed Aladdin
errShare
errSave
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
errInfectious Diseases and Therapy
IF5.3
err2026-07-24
err0
errOAAI
errAnnefleur C. Langedijk; Floris van den Dungen; Frits M. E. Franssen; Marco Goeijenbier; Ahuva Averin; Erin Quinn; Mark Atwood; Diana Mendes
errShare
errSave
The Clinical and Symptomatic Burden Among Older Adults with Respiratory Syncytial Virus: A Real-World Survey in Five European Countries
errInfectious Diseases and Therapy
IF5.3
err2026-06-13
err0
errOAAI
errDiana Mendes; James Lucas; Emily Quinones; Mayesha Chowdhury; Libby Turner; Stéphane Fiévez; Caroline Lade; Roberto Di Virgilio; Alejandra López-Ibáñez de Aldecoa; James Piercy; Reiko Sato
errShare
errSave
What Form of RSV Protection Do Women Prefer: Maternal Vaccination or Infant Immunisation? A Cross-Sectional Survey in Europe
errVaccines
IF3.4
err2026-03-05
err0
errOAAI
errDiana Mendes; Malvin Kang; Amy Law
errShare
errSave
Cost-effectiveness of strategies using preventive interventions to protect infants in Chile from respiratory syncytial virus
errEXPERT REVIEW OF VACCINES
IF4.8
err2025-12-31
err0
PREAI
errBolanos, Rafael; Araos, Rafael; Gonzalez, Cecilia; Sepulveda, Dino; Falconi, Juan Francisco; Averin, Ahuva; Atwood, Mark; Quinn, Erin; Law, Amy W.; Mendes, Diana
errShare
errSave
Preferences of Dutch Parents and Expectant Parents for Respiratory Syncytial Virus Prevention Strategies: A Discrete Choice Experiment
errInfectious Diseases and Therapy
IF5.3
err2025-09-23
err0
errOAAI
errAnnefleur C. Langedijk; Floris van den Dungen; Lisette Harteveld; Lisanne van Leeuwen; Lucy Smit; Jennie van den Boer; Diana Mendes; M. Claire Verhage; Elise Kocks; Marlies van Houten
errShare
errSave
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan
errExpert Review of Vaccines
IF4.8
err2025-07-22
err0
errOAAI
errClaud Theakston; Matthew Napier; Simon Brassel; Kazumasa Kamei; Shuhei Ito; Jeffrey Vietri; Diana Mendes; Jingyan Yang; Tianyan Hu; Lotte Steuten
errShare
errSave
The broader socio-economic value of adult respiratory disease vaccinations in the UK – results from a benefit cost analysis
errExpert Review of Vaccines
IF4.8
err2025-07-22
err0
errOAAI
errCale Harrison; Simon Brassel; Sulayman Chowdhury; Claud Theakston; Matthew Napier; Jeffrey Vietri; Diana Mendes; Jingyan Yang; Tianyan Hu; Lotte Steuten
errShare
errSave
Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus
errHuman Vaccines & Immunotherapeutics
IF3.5
err2025-07-02
err0
errOAAI
errMostafa Zayed; Jean Joury; Mohamed Farghaly; Sara Al Dallal; Ramya Mahendiran; Amy W. Law; Diana Mendes; Erin Quinn; Emily Kutrieb; Ahuva Averin
errShare
errSave
Cost-effectiveness of immunization strategies to protect infants against respiratory syncytial virus in the Netherlands
errHuman Vaccines & Immunotherapeutics
IF3.5
err2025-06-25
err0
errOAAI
errAnnefleur C. Langedijk; Floris van den Dungen; Lisette Harteveld; Jennie van den Boer; Lucy Smit; Ahuva Averin; Erin Quinn; Mark Atwood; Amy Law; Diana Mendes; Marlies van Houten
errShare
errSave
The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021-2022
errBMC INFECTIOUS DISEASES
IF3
err2025-02-13
err0
errOAAI
errYang, Jingyan; Rai, Kiran K.; Alfred, Tamuno; Massey, Lucy; Massey, Olivia; Mcgrath, Leah; Andersen, Kathleen M.; Tritton, Theo; Tsang, Carmen; Butfield, Rebecca; Reynard, Charlie; Mendes, Diana; Nguyen, Jennifer L.
errShare
errSave
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
errVACCINES
IF3.4
err2025-01-16
err0
errOAAI
errHuerta, Jose Luis; Kendall, Robyn; Ivkovic, Luka; Molina, Carlos; Law, Amy W.; Mendes, Diana
errShare
errSave
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece
errVACCINES
IF3.4
err2024-10-29
err0
errOAAI
errGourzoulidis, George; Tzanetakos, Charalampos; Solakidi, Argyro; Markatis, Eleftherios; Detsis, Marios; Mendes, Diana; Barmpouni, Myrto
errShare
errSave
Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection
errHEALTH AND QUALITY OF LIFE OUTCOMES
IF3.4
err2024-01-30
err5
errOAAI
errSoare, Ioana-Alexandra; Ansari, Wajeeha; Nguyen, Jennifer L.; Mendes, Diana; Ahmed, Waqas; Atkinson, Joanna; Scott, Amie; Atwell, Jessica E.; Longworth, Louise; Becker, Frauke
errShare
errSave
Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom
errVACCINES
IF3.4
err2023-06-28
err12
errOAAI
errWilson, Michele; Lucas, Aaron; Mendes, Diana; Vyse, Andrew; Mikudina, Boglarka; Czudek, Carole; Ellsbury, Gillian Frances; Perdrizet, Johnna
errShare
errSave
Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2023-06-08
err24
errOAAI
errHamson, Elizabeth; Forbes, Carol; Wittkopf, Priscilla; Pandey, Anuja; Mendes, Diana; Kowalik, Jack; Czudek, Carole; Mugwagwa, Tendai
errShare
errSave
Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?
errVACCINES
IF3.4
err2023-05-04
err4
errOAAI
errNeri, Margherita; Brassel, Simon; Schirrmacher, Hannah; Mendes, Diana; Vyse, Andrew; Steuten, Lotte; Hamson, Elizabeth
errShare
errSave
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study
errVACCINES
IF3.4
err2023-01-20
err5
errOAAI
errDi Fusco, Manuela; Mendes, Diana; Steuten, Lotte; Bloom, David E.; Drummond, Michael; Hauck, Katharina; Pearson-Stuttard, Jonathan; Power, Rachel; Salisbury, David; Towse, Adrian; Roiz, Julie; Szabo, Gabor; Yang, Jingyan; Marczell, Kinga
errShare
errSave
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance
errEXPERT REVIEW OF VACCINES
IF4.8
err2023-01-03
err10
errOAAI
errMendes, Diana; Chapman, Ruth; Aruffo, Elena; Gal, Peter; Nguyen, Jennifer L.; Hamson, Libby; Di Fusco, Manuela; Czudek, Carole; Yang, Jingyan
errShare
errSave
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England
errEXPERT REVIEW OF VACCINES
IF4.8
err2022-08-08
err3
errOAAI
errMugwagwa, Tendai; Averin, Ahuva; Atwood, Mark; Sato, Reiko; Vyse, Andrew; Campling, James; Weycker, Derek; Slack, Mary; Ellsbury, Gillian; Mendes, Diana
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
David Cunningham
H-index: 153 · Papers: 2.1K
F
Francesco Landi
H-index: 113 · Papers: 604
D
David E. Bloom
H-index: 92 · Papers: 730
M
Mark Jit
H-index: 90 · Papers: 644
M
Michael Drummond
H-index: 75 · Papers: 592
View more